# Acro Biomedical Co., Ltd.

- Location (FDA's records): Kaohsiung City, TW
- FDA decisions: 4 (2017–2024): 4 510(k) clearances
- Product codes: KGN (2), MQV (2)
- 510(k) review time since 2016: median 253 days, against 106 for FDA's reviews in the same codes and years (0 of 4 faster)
- Predicates its devices cite: 5 (2 its own); citations of its devices by later devices: 2 (2 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Collamatrix Co., Inc.: 1 (https://510kreport.com/company/collamatrix)
- Ed. Geistlich Soehne AG Fur Chemische Industrie: 1 (https://510kreport.com/company/ed-geistlich-soehne-ag-fur-chemische-industrie)
- Wiltrom Corporation Limited: 1 (https://510kreport.com/company/wiltrom)

## Its most-cited devices
- K162348: ABCcolla Collagen Matrix (2017), cited by 1
- K171629: ABCcolla Bone Graft (2018), cited by 1

## Recent decisions
- K233378: ABCcolla® Collagen ADM Scaffold (Oct 18, 2024)
- K212156: ABCcolla Bone Matrix (Oct 8, 2021)
- K171629: ABCcolla Bone Graft (Feb 1, 2018)
- K162348: ABCcolla Collagen Matrix (May 10, 2017)

Source page: https://510kreport.com/company/acro-biomedical